Summit Therapeutics Inc. (SMMT)
USD 16.64
(-3.93%)
USD 16.64
(-3.93%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -614.92 Million USD | -726.73% |
| 2022 | -74.38 Million USD | 13.66% |
| 2021 | -86.14 Million USD | -63.48% |
| 2020 | -52.69 Million USD | -71.86% |
| 2019 | -30.66 Million USD | -410.59% |
| 2018 | 9.87 Million GBP | 197.8% |
| 2017 | -10.09 Million GBP | 62.21% |
| 2016 | -26.71 Million GBP | -9.76% |
| 2015 | -24.33 Million GBP | -42.15% |
| 2014 | -17.12 Million GBP | -70.35% |
| 2013 | -10.05 Million GBP | -50.6% |
| 2012 | -6.67 Million GBP | -57.75% |
| 2011 | -4.23 Million GBP | 43.0% |
| 2010 | -7.42 Million GBP | 14.27% |
| 2009 | -8.65 Million GBP | 73.19% |
| 2008 | -32.28 Million GBP | -60.42% |
| 2007 | -20.12 Million GBP | -239.78% |
| 2006 | -5.92 Million GBP | -212.88% |
| 2005 | -1.89 Million GBP | -2085.96% |
| 2004 | -86.61 Thousand GBP | -106.4% |
| 2003 | -41.96 Thousand GBP | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -56.25 Million USD | 6.84% |
| 2024 Q1 | -43.47 Million USD | -18.89% |
| 2024 Q2 | -60.38 Million USD | -38.9% |
| 2023 Q1 | -1.58 Billion USD | -9582.85% |
| 2023 Q2 | -14.71 Million USD | 99.07% |
| 2023 Q3 | -21.26 Million USD | -44.51% |
| 2023 FY | -614.92 Million USD | -726.73% |
| 2023 Q4 | -36.56 Million USD | -71.93% |
| 2022 Q4 | -16.32 Million USD | 36.8% |
| 2022 Q1 | -20.63 Million USD | 23.85% |
| 2022 Q2 | -16.77 Million USD | 18.73% |
| 2022 FY | -74.38 Million USD | 13.66% |
| 2022 Q3 | -25.83 Million USD | -54.02% |
| 2021 Q4 | -27.09 Million USD | -38.27% |
| 2021 Q3 | -19.59 Million USD | 19.73% |
| 2021 Q2 | -24.41 Million USD | -39.62% |
| 2021 FY | -86.14 Million USD | -63.48% |
| 2021 Q1 | -17.48 Million USD | -29.15% |
| 2020 FY | -52.69 Million USD | -71.86% |
| 2020 Q2 | -15.23 Million USD | -149.4% |
| 2020 Q3 | -17.7 Million USD | -16.22% |
| 2020 Q4 | -13.54 Million USD | 23.5% |
| 2020 Q1 | -6.1 Million GBP | 31.03% |
| 2019 FY | -30.66 Million USD | -410.59% |
| 2019 Q4 | -8.85 Million USD | 2.36% |
| 2019 Q3 | -9.06 Million GBP | -44.56% |
| 2019 Q2 | -6.27 Million GBP | -20.53% |
| 2019 Q1 | -5.2 Million GBP | 23.08% |
| 2018 FY | 9.87 Million GBP | 197.8% |
| 2018 Q4 | -6.76 Million GBP | 34.49% |
| 2018 Q3 | -10.32 Million GBP | -129.53% |
| 2018 Q2 | 34.98 Million GBP | 535.42% |
| 2018 Q1 | -8.03 Million GBP | 50.72% |
| 2017 Q4 | -16.3 Million GBP | -596.41% |
| 2017 Q1 | -6.15 Million GBP | -0.0% |
| 2017 FY | -10.09 Million GBP | 62.21% |
| 2017 Q3 | -2.34 Million GBP | -116.31% |
| 2017 Q2 | 14.35 Million GBP | 333.16% |
| 2016 Q4 | -6.15 Million GBP | -10.03% |
| 2016 Q3 | -5.59 Million GBP | 31.85% |
| 2016 FY | -26.71 Million GBP | -9.76% |
| 2016 Q1 | -7.65 Million GBP | -6.96% |
| 2016 Q2 | -8.2 Million GBP | -7.19% |
| 2015 Q3 | -7.19 Million GBP | -14.29% |
| 2015 Q4 | -7.16 Million GBP | 0.43% |
| 2015 FY | -24.33 Million GBP | -42.15% |
| 2015 Q2 | -6.29 Million GBP | -21.2% |
| 2015 Q1 | -5.19 Million GBP | -14.48% |
| 2014 Q2 | -5.54 Million GBP | -25.69% |
| 2014 FY | -17.12 Million GBP | -70.35% |
| 2014 Q1 | -4.41 Million GBP | -12.22% |
| 2014 Q4 | -4.53 Million GBP | -15.86% |
| 2014 Q3 | -3.91 Million GBP | 29.46% |
| 2013 Q2 | -1.06 Million USD | 0.0% |
| 2013 Q3 | -2.85 Million GBP | -167.12% |
| 2013 Q1 | -1.06 Million USD | -7.22% |
| 2013 Q4 | -3.93 Million GBP | -37.7% |
| 2013 FY | -10.05 Million GBP | -50.6% |
| 2012 Q2 | -1.11 Million USD | 0.0% |
| 2012 Q1 | -1.11 Million USD | -77.69% |
| 2012 Q4 | -997.5 Thousand USD | 0.0% |
| 2012 Q3 | -997.5 Thousand USD | 10.54% |
| 2012 FY | -6.67 Million GBP | -57.75% |
| 2011 Q4 | -627.5 Thousand USD | 0.0% |
| 2011 Q3 | -627.5 Thousand USD | 0.0% |
| 2011 FY | -4.23 Million GBP | 43.0% |
| 2010 FY | -7.42 Million GBP | 14.27% |
| 2009 FY | -8.65 Million GBP | 73.19% |
| 2008 FY | -32.28 Million GBP | -60.42% |
| 2007 FY | -20.12 Million GBP | -239.78% |
| 2006 FY | -5.92 Million GBP | -212.88% |
| 2005 FY | -1.89 Million GBP | -2085.96% |
| 2004 FY | -86.61 Thousand GBP | -106.4% |
| 2003 FY | -41.96 Thousand GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1084.262% |
| Jaguar Health, Inc. | -41.3 Million USD | -1388.93% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -301.935% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -1029.925% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -39.68% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1279.062% |
| ContextLogic Inc. | -317 Million USD | -93.984% |
| MiMedx Group, Inc. | 67.43 Million USD | 1011.828% |
| MEI Pharma, Inc. | 17.77 Million USD | 3558.927% |
| AlloVir, Inc. | -190.41 Million USD | -222.936% |
| Novavax, Inc. | -545.06 Million USD | -12.818% |
| Aptorum Group Limited | -2.82 Million USD | -21670.083% |
| Ardelyx, Inc. | -66.06 Million USD | -830.764% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -199.563% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1101.993% |
| Vaxcyte, Inc. | -402.26 Million USD | -52.866% |
| Precigen, Inc. | -95.9 Million USD | -541.191% |
| Pharming Group N.V. | -10.54 Million USD | -5729.807% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -205.036% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2405.513% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2350.791% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -189.76% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -3215.674% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2426.483% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2426.483% |
| Bicycle Therapeutics plc | -180.66 Million USD | -240.371% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -138.5% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2157.611% |
| Acelyrin, Inc. | -381.64 Million USD | -61.127% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1546.834% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1703.255% |
| Senti Biosciences, Inc. | -92.91 Million USD | -561.789% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -487.329% |
| AbCellera Biologics Inc. | -146.39 Million USD | -320.039% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1649.937% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -243.434% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -9098.624% |
| Chimerix, Inc. | -82.09 Million USD | -649.044% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1994.299% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2930.546% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1278.66% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1104.371% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1245.458% |
| Alkermes plc | 355.75 Million USD | 272.851% |
| Fortress Biotech, Inc. | -60.63 Million USD | -914.113% |
| Fortress Biotech, Inc. | -60.63 Million USD | -914.113% |
| Agenus Inc. | -245.76 Million USD | -150.214% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -653.773% |
| Dyadic International, Inc. | -6.79 Million USD | -8949.099% |
| ImmuCell Corporation | -5.77 Million USD | -10548.845% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -65597.436% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -444.372% |
| Lantern Pharma Inc. | -15.96 Million USD | -3752.562% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3886.296% |
| Incyte Corporation | 597.59 Million USD | 202.9% |
| IO Biotech, Inc. | -86.08 Million USD | -614.343% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -954.892% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -3131.551% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -942.557% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -273.648% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -7133.596% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -738.382% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -64.582% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -7.347% |
| NextCure, Inc. | -62.72 Million USD | -880.387% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -6057.901% |
| Onconetix, Inc. | -37.4 Million USD | -1543.766% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1457.608% |
| Opthea Limited | -220.24 Million USD | -179.205% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1331.99% |
| PureTech Health plc | -65.69 Million USD | -836.006% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -733.349% |
| Seer, Inc. | -86.27 Million USD | -612.737% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4902580.366% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1792.96% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4604.211% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -2061.282% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -969.198% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -887.757% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -364.121% |
| ChromaDex Corporation | -4.93 Million USD | -12352.977% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -17038.462% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -502.457% |
| CRISPR Therapeutics AG | -153.61 Million USD | -300.318% |
| Precision BioSciences, Inc. | -61.31 Million USD | -902.834% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -282.114% |
| Innoviva, Inc. | 179.72 Million USD | 442.155% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -817.871% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -835.038% |
| ESSA Pharma Inc. | -26.58 Million USD | -2213.295% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1566.498% |
| GT Biopharma, Inc. | -7.59 Million USD | -7994.353% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -154.775% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 961.123% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1151.889% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -6081.581% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -150.383% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1100.867% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -525.576% |
| Soligenix, Inc. | -6.14 Million USD | -9913.923% |
| Century Therapeutics, Inc. | -136.67 Million USD | -349.926% |
| Kura Oncology, Inc. | -152.63 Million USD | -302.885% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -589.242% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -5735.339% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 108846.353% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -107971.705% |
| Autolus Therapeutics plc | -208.38 Million USD | -195.095% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -755.278% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -768.604% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2737.955% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -172.998% |
| GRI Bio, Inc. | -13.03 Million USD | -4616.791% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -14772.812% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -395.574% |
| IGM Biosciences, Inc. | -246.41 Million USD | -149.549% |
| INmune Bio, Inc. | -30 Million USD | -1949.214% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -456.199% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1357.39% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3752.532% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3793.186% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -930.289% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -507.835% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -122.698% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -158.49% |
| Verastem, Inc. | -87.36 Million USD | -603.845% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -1034.805% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -281.147% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -427.12% |
| Histogen Inc. | -10.62 Million USD | -5689.737% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -4204.182% |
| Surrozen, Inc. | -43.04 Million USD | -1328.67% |
| Organovo Holdings, Inc. | -14.67 Million USD | -4091.453% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11988.156% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1074.895% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2334.105% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2182.753% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -7258.163% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -307.008% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1156.852% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1968.723% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5802.721% |
| Apollomics, Inc. | -172.6 Million USD | -256.271% |
| Amarin Corporation plc | -59.11 Million USD | -940.276% |
| Mesoblast Limited | -87.95 Million USD | -599.131% |
| Turnstone Biologics Corp. | -55.2 Million USD | -1014.0% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -318.427% |
| Synaptogenix, Inc. | -6.03 Million USD | -10083.449% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3693.978% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -688.167% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12733.817% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -7218.658% |
| Exelixis, Inc. | 207.76 Million USD | 395.973% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1446.6% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -327.188% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -16.325% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4951.976% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -7789.063% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1899.831% |
| Gritstone bio, Inc. | -138.49 Million USD | -344.023% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -853.894% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -15273.392% |
| Avid Bioservices, Inc. | -140.75 Million USD | -336.884% |
| Insmed Incorporated | -749.56 Million USD | 17.962% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3948.373% |
| MediWound Ltd. | -6.71 Million USD | -9056.164% |
| OmniAb, Inc. | -50.61 Million USD | -1114.817% |
| Alector, Inc. | -130.39 Million USD | -371.603% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -440.72% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1086.044% |
| Zai Lab Limited | -334.62 Million USD | -83.769% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -89.801% |
| Aura Biosciences, Inc. | -76.4 Million USD | -704.795% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -162.082% |
| Immunic, Inc. | -93.61 Million USD | -556.89% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -352.509% |
| Veracyte, Inc. | -74.4 Million USD | -726.472% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -7911.517% |
| FibroGen, Inc. | -284.23 Million USD | -116.347% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2244.19% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -8682.314% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -3165.215% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 248.235% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2626.349% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1348.053% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4952.652% |
| Galecto, Inc. | -38.34 Million USD | -1503.505% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -3159.451% |
| Fortrea Holdings Inc. | -3.4 Million USD | -17986.118% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -385.556% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3431.836% |
| XBiotech Inc. | -24.55 Million USD | -2404.084% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -853.894% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -881.059% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -524.762% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2769.874% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -1014.141% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -1.366% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -800.927% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1079971.662% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -171.445% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2661.547% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -179.882% |
| NexImmune, Inc. | -32.34 Million USD | -1801.189% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -11531.881% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -4277.991% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 115.554% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2438.822% |
| Scopus BioPharma Inc. | -11.6 Million USD | -5196.616% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -426.488% |
| Ainos, Inc. | -13.77 Million USD | -4365.53% |
| Pluri Inc. | -20.88 Million USD | -2843.93% |
| Prothena Corporation plc | -147.02 Million USD | -318.239% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -440.022% |
| Celularity Inc. | -196.29 Million USD | -213.267% |
| Rallybio Corporation | -74.56 Million USD | -724.698% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1112.087% |
| MeiraGTx Holdings plc | -84.02 Million USD | -631.822% |
| Omeros Corporation | -117.81 Million USD | -421.953% |
| Humacyte, Inc. | -110.77 Million USD | -455.109% |
| Immunocore Holdings plc | -55.28 Million USD | -1012.247% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -3319.306% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2581.645% |
| Blueprint Medicines Corporation | -506.98 Million USD | -21.291% |
| CalciMedica, Inc. | -34.35 Million USD | -1689.819% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -808.649% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -334.87% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -270.91% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -117.093% |
| Pulmatrix, Inc. | -14.12 Million USD | -4254.706% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1647.203% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -644.123% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -27.793% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -486.366% |
| Cytokinetics, Incorporated | -526.24 Million USD | -16.852% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1605.055% |
| Nutriband Inc. | -5.48 Million USD | -11110.443% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1421.346% |
| Vor Biopharma Inc. | -117.86 Million USD | -421.731% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 114.14% |
| Evogene Ltd. | -23.87 Million USD | -2475.183% |
| ProKidney Corp. | -35.46 Million USD | -1633.754% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -413.454% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -7738.081% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 4.396% |
| CorMedix Inc. | -46.33 Million USD | -1227.014% |
| BioLineRx Ltd. | -60.61 Million USD | -914.498% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -504.387% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1397.414% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1428.759% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -662.463% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -714.248% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -110.454% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -2105.941% |
| MediciNova, Inc. | -8.57 Million USD | -7074.087% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -398.818% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7240.816% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2268.135% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -157.036% |
| Biomea Fusion, Inc. | -117.25 Million USD | -424.436% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 1.863% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1986.907% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -301.489% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -193.718% |
| Absci Corporation | -110.56 Million USD | -456.164% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1939.562% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -509.824% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -160.632% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 4466.146% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -218.678% |
| Allakos Inc. | -185.7 Million USD | -231.139% |
| Imunon, Inc. | -19.51 Million USD | -3051.057% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -531.765% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 679.356% |
| BioAtla, Inc. | -123.46 Million USD | -398.071% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4951.976% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3724.655% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -87.899% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1564.262% |
| XOMA Corporation | -40.83 Million USD | -1406.032% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -503.64% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -418.87% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1120.362% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -601.34% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -305.2% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -158.662% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1650.984% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -7499.265% |
| Akari Therapeutics, Plc | -10 Million USD | -6044.365% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -913272.447% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 318.374% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9126.366% |
| UroGen Pharma Ltd. | -102.24 Million USD | -501.432% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -475.813% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -7806.821% |
| Orgenesis Inc. | -55.36 Million USD | -1010.76% |
| Entera Bio Ltd. | -8.88 Million USD | -6817.854% |
| GH Research PLC | -35.58 Million USD | -1627.957% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2850.71% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -694.604% |
| Xencor, Inc. | -126.08 Million USD | -387.701% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -16229.704% |
| Replimune Group, Inc. | -215.79 Million USD | -184.961% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2791.529% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 24608.888% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9126.366% |
| Portage Biotech Inc. | -75.33 Million USD | -716.215% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7240.816% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -536.209% |
| OncoCyte Corporation | -27.78 Million USD | -2113.484% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -4483.128% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -5429.172% |
| Purple Biotech Ltd. | -19.88 Million USD | -2993.199% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -8660.906% |
| scPharmaceuticals Inc. | -54.81 Million USD | -1021.927% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3412.641% |
| HilleVax, Inc. | -123.56 Million USD | -397.651% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5984.179% |
| Tharimmune, Inc. | -9.31 Million USD | -6498.581% |
| Genprex, Inc. | -30.86 Million USD | -1892.608% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -160.646% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1943.357% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -34407.744% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -11511.145% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3654647.032% |
| Savara Inc. | -54.69 Million USD | -1024.224% |
| Curis, Inc. | -47.41 Million USD | -1196.961% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1938.792% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3881.383% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -10941.982% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1962.479% |
| BeiGene, Ltd. | -881.7 Million USD | 30.257% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2787.799% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -40.92% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -678.834% |
| Erasca, Inc. | -125.04 Million USD | -391.777% |
| bluebird bio, Inc. | -211.91 Million USD | -190.179% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12197.338% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 466.804% |
| DBV Technologies S.A. | -72.72 Million USD | -745.541% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12197.338% |
| Moderna, Inc. | -4.71 Billion USD | 86.955% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1431.31% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -10699.579% |
| Molecular Templates, Inc. | -8.12 Million USD | -7469.276% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -918.295% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -452.005% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -354.318% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1183.266% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -334.796% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -219.593% |
| MacroGenics, Inc. | -9.05 Million USD | -6688.783% |
| RenovoRx, Inc. | -10.23 Million USD | -5909.851% |
| Adicet Bio, Inc. | -142.65 Million USD | -331.05% |
| Prime Medicine, Inc. | -198.13 Million USD | -210.361% |
| Aditxt, Inc. | -32.38 Million USD | -1799.049% |
| Adagene Inc. | -18.94 Million USD | -3145.624% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8310.165% |
| Quantum-Si incorporated | -95.96 Million USD | -540.817% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -416.62% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4118.259% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 564.693% |
| SciSparc Ltd. | -5.12 Million USD | -11905.623% |
| Vericel Corporation | -3.18 Million USD | -19225.204% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -511257.626% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1949.394% |
| Generation Bio Co. | -126.61 Million USD | -385.679% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -743.627% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -645.892% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -134.58% |
| Invivyd, Inc. | -198.64 Million USD | -209.564% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -79.818% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -6979.063% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2796.343% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -6127.75% |
| 2seventy bio, Inc. | -217.57 Million USD | -182.635% |
| ADMA Biologics, Inc. | -28.23 Million USD | -2077.584% |
| Clene Inc. | -49.5 Million USD | -1142.178% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2659.066% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1143.937% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2268.135% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -87.44% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1789.591% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2806.549% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -522.449% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -722.602% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -282.406% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 0.022% |
| Evaxion Biotech A/S | -22.12 Million USD | -2679.336% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -661.653% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -207.359% |
| Trevena, Inc. | -40.28 Million USD | -1426.293% |
| Surrozen, Inc. | -43.04 Million USD | -1328.67% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -789.473% |
| Cingulate Inc. | -23.53 Million USD | -2512.829% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -8796.528% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1442.72% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -7875.024% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -581.663% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -903.374% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -933.44% |
| Clearmind Medicine Inc. | -11.95 Million USD | -5043.675% |
| Kronos Bio, Inc. | -112.67 Million USD | -445.763% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -788.663% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -24245650.583% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -615.907% |
| Statera Biopharma, Inc. | -174.4 Million USD | -252.58% |
| ImmunityBio, Inc. | -583.19 Million USD | -5.441% |
| Korro Bio, Inc. | -81.17 Million USD | -657.562% |
| Kineta, Inc. | -14.09 Million USD | -4261.501% |
| BioVie Inc. | -32.12 Million USD | -1814.439% |
| Codexis, Inc. | -76.24 Million USD | -706.569% |
| Celularity Inc. | -196.29 Million USD | -213.267% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -186.641% |
| Celcuity Inc. | -63.77 Million USD | -864.153% |
| Virax Biolabs Group Limited | -6.73 Million USD | -9032.318% |
| Cibus, Inc. | -267.62 Million USD | -129.771% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1424.892% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1617.148% |
| IN8bio, Inc. | -30 Million USD | -1949.282% |
| Kodiak Sciences Inc. | -260.49 Million USD | -136.065% |
| Annexon, Inc. | -134.23 Million USD | -358.091% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -424.839% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -904.325% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1849.429% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -67.882% |
| Eyenovia, Inc. | -27.26 Million USD | -2155.698% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2948.076% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -114839.813% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -704.837% |
| Arcellx, Inc. | -70.69 Million USD | -769.894% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1383.864% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -359.532% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1947.235% |
| Moolec Science SA | -51.78 Million USD | -1087.375% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1074.177% |
| Geron Corporation | -184.12 Million USD | -233.969% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1365.021% |
| Royalty Pharma plc | 1.13 Billion USD | 154.187% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -352.299% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -6815.673% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2794.701% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -258.204% |
| Humacyte, Inc. | -110.77 Million USD | -455.109% |
| Structure Therapeutics Inc. | -89.62 Million USD | -586.15% |
| 89bio, Inc. | -142.18 Million USD | -332.472% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -791.717% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5825.875% |
| Genelux Corporation | -28.29 Million USD | -2073.121% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -2015.699% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -247.184% |
| Notable Labs, Ltd. | -11.26 Million USD | -5359.233% |
| Liquidia Corporation | -78.5 Million USD | -683.328% |
| Mustang Bio, Inc. | -51.6 Million USD | -1091.675% |
| Immunovant, Inc. | -259.33 Million USD | -137.116% |
| Quantum-Si incorporated | -95.96 Million USD | -540.817% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -744.113% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -3072.839% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -540.617% |
| Acasti Pharma Inc. | -12.85 Million USD | -4684.315% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2638.142% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3752.532% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -237.145% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -14195.608% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4831.259% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1985.138% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1477.224% |
| PepGen Inc. | -78.62 Million USD | -682.092% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1965.666% |
| United Therapeutics Corporation | 984.8 Million USD | 162.442% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2662.48% |
| Solid Biosciences Inc. | -96.01 Million USD | -540.45% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12733.817% |
| Immuneering Corporation | -53.47 Million USD | -1050.008% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11988.156% |
| Silo Pharma, Inc. | -3.7 Million USD | -16516.608% |
| Belite Bio, Inc | -31.63 Million USD | -1844.006% |
| XOMA Corporation | -40.83 Million USD | -1406.032% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -1031.11% |
| Bionomics Limited | -15.49 Billion USD | 96.031% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -632.188% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2009.024% |
| uniQure N.V. | -308.47 Million USD | -99.343% |
| Cassava Sciences, Inc. | -97.21 Million USD | -532.531% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8310.165% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -398.2% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1853.641% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -7397.565% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -2015.481% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -114839.813% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2244.19% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3630.227% |
| Altimmune, Inc. | -88.44 Million USD | -595.25% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -305.668% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2009.024% |
| Compugen Ltd. | -18.75 Million USD | -3178.916% |
| Peak Bio, Inc. | -1259.26 USD | -48832388.922% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1235.378% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2727.125% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -81.507% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -641.288% |
| Zura Bio Limited | -60.36 Million USD | -918.767% |
| PolyPid Ltd. | -23.86 Million USD | -2476.694% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3808.772% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -641.288% |
| Instil Bio, Inc. | -156.08 Million USD | -293.965% |
| argenx SE | -295.05 Million USD | -108.413% |
| Immunome, Inc. | -106.8 Million USD | -475.743% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1347.094% |
| Verona Pharma plc | -54.36 Million USD | -1031.027% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -515.439% |
| Shattuck Labs, Inc. | -87.29 Million USD | -604.401% |
| CervoMed Inc. | -2.17 Million USD | -28213.258% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -393.32% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -4517.963% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1311.842% |
| Moolec Science SA | -51.78 Million USD | -1087.375% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3556097.095% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -355.107% |
| AnaptysBio, Inc. | -163.61 Million USD | -275.829% |
| Design Therapeutics, Inc. | -66.86 Million USD | -819.697% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -655.31% |
| NeurAxis, Inc. | -14.62 Million USD | -4104.152% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1523.272% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1706.805% |
| Achilles Therapeutics plc | -69.66 Million USD | -782.693% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -515.439% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2984.648% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 20537.717% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -24245650.583% |
| Nutriband Inc. | -5.48 Million USD | -11110.443% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -510.672% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1165.102% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -697.665% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1710.209% |
| MoonLake Immunotherapeutics | -36 Million USD | -1607.789% |
| Palisade Bio, Inc. | -12.3 Million USD | -4899.415% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1359.804% |
| Beam Therapeutics Inc. | -132.52 Million USD | -364.002% |
| Neurogene Inc. | -36.31 Million USD | -1593.224% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -276.298% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1070.043% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -526.538% |
| Sesen Bio, Inc. | -19.88 Million USD | -2992.577% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -759.03% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4813.961% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -38.486% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -451.179% |
| Athira Pharma, Inc. | -117.67 Million USD | -422.578% |
| Vaccinex, Inc. | -20.25 Million USD | -2936.532% |
| HCW Biologics Inc. | -24.99 Million USD | -2360.275% |
| XOMA Corporation | -40.83 Million USD | -1406.032% |
| Nektar Therapeutics | -276.05 Million USD | -122.755% |
| Arvinas, Inc. | -367.3 Million USD | -67.418% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -913272.447% |
| Merus N.V. | -154.93 Million USD | -296.884% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -531.161% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1859.305% |
| Rezolute, Inc. | -68.45 Million USD | -798.243% |
| Clene Inc. | -49.5 Million USD | -1142.178% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3886.962% |
| BeyondSpring Inc. | -21.02 Million USD | -2824.608% |
| Synlogic, Inc. | -57.28 Million USD | -973.51% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -5067.028% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5580.103% |
| Peak Bio, Inc. | -1259.26 USD | -48832388.922% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1545.601% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5725.027% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -329.722% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -89.148% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -13213.112% |
| MannKind Corporation | -11.93 Million USD | -5051.014% |
| Ikena Oncology, Inc. | -68.16 Million USD | -802.104% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2826.138% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -561.69% |
| Gossamer Bio, Inc. | -179.81 Million USD | -241.974% |
| CohBar, Inc. | -11.96 Million USD | -5040.628% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2284.551% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1939.562% |
| Legend Biotech Corporation | -518.25 Million USD | -18.654% |
| Mural Oncology plc | -207.44 Million USD | -196.427% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -395.45% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3262.15% |
| Disc Medicine, Inc. | -76.42 Million USD | -704.574% |
| Champions Oncology, Inc. | -7.27 Million USD | -8351.457% |
| REGENXBIO Inc. | -263.49 Million USD | -133.375% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5694.061% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1194.449% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1518.935% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -513.927% |
| Vaxart, Inc. | -82.46 Million USD | -645.684% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 184340.913% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1537.951% |
| Cellectis S.A. | -101.05 Million USD | -508.484% |
| Longeveron Inc. | -21.41 Million USD | -2771.751% |
| Repare Therapeutics Inc. | -93.79 Million USD | -555.602% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -14.73% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -764.039% |
| Revolution Medicines, Inc. | -436.36 Million USD | -40.92% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -9258.21% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1894.965% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -786.92% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -849.96% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -6167.74% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 116.989% |
| Denali Therapeutics Inc. | -145.22 Million USD | -323.434% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -511257.626% |
| Veru Inc. | -93.15 Million USD | -560.129% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2175.068% |
| Cingulate Inc. | -23.53 Million USD | -2512.829% |
| Passage Bio, Inc. | -102.06 Million USD | -502.504% |
| Context Therapeutics Inc. | -23.96 Million USD | -2466.026% |
| Exicure, Inc. | -16.91 Million USD | -3535.615% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -225.502% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1528.344% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -9349.782% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -232.973% |
| Nuvalent, Inc. | -126.21 Million USD | -387.191% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -5747.738% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -607.798% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1913.253% |
| OmniAb, Inc. | -50.61 Million USD | -1114.817% |
| Anew Medical, Inc. | 1.34 Million USD | 45781.345% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3732.521% |
| Lipocine Inc. | -16.35 Million USD | -3660.549% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -826.18% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -865.729% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1357.39% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1181.981% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -3000.842% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -13.562% |
| Ocugen, Inc. | -63.07 Million USD | -874.869% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -542.343% |
| Q32 Bio Inc. | -112.96 Million USD | -444.372% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3476.826% |
| Alumis Inc. Common Stock | -154.99 Million USD | -296.746% |
| Equillium, Inc. | -13.33 Million USD | -4511.384% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -918.666% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -7598.305% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -3162.005% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -940.804% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -436.928% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3246.009% |
| Dominari Holdings Inc. | -22.88 Million USD | -2587.387% |
| Edesa Biotech, Inc. | -8.37 Million USD | -7242.937% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2936.681% |
| Bio-Techne Corporation | 168.1 Million USD | 465.8% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -74.652% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 577.232% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -404.734% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1520.833% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -445.914% |
| Nkarta, Inc. | -117.5 Million USD | -423.339% |
| BioCardia, Inc. | -11.57 Million USD | -5214.389% |
| Iterum Therapeutics plc | -38.37 Million USD | -1502.585% |